While miR-21 and miR-31 have been shown to play a direct role in regulating Kras-driven lung tumorigenesis in vivo[74,75], whether they play a similar role in lung cancer driven by other oncogenic drivers, including IGFIR, remains unknown. Here, KRAS is linked to lung carcinoma.